Improved isolation of mycobacteria other than Mycobacterium tuberculosis on isoniazid-containing Löwenstein-Jensen medium.
The benefit of including isoniazid-containing Löwenstein-Jensen medium for primary isolation of mycobacteria was evaluated in 3,726 clinical specimens. This media increased the primary isolation of mycobacteria other than Mycobacterium tuberculosis by 9.2%, facilitated macroscopical reading and aided presumptive identification of the isolated mycobacteria.
D003470:Culture Media; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid; D009161:Mycobacterium / Q000302:isolation & purification*; D009170:Nontuberculous Mycobacteria / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*
D003470:Culture Media; D007538:Isoniazid